| Literature DB >> 34398404 |
Wentao Zhang1, Tao Sheng1, Zhen Gu2,3,4,5, Yuqi Zhang6.
Abstract
Obesity expands as a global climbing epidemic that is often correlated to cardiovascular diseases and endocrine disorders. Converting white adipocytes to brown adipocytes for enhanced energy expenditure has recently emerged as a promising anti-obesity treatment. However, the conventional approaches to apply browning agents systematically suffer from off-target effects, multiple dosage requirements, and poor patient compliance. To date, various delivery strategies have been reported to deliver browning agents for obesity treatment in a safer and more controllable manner. This review will discuss the latest designs in browning agent delivery systems with a focus on nanomedicines and transdermal patches.Entities:
Keywords: adipocyte; browning agent; drug delivery; nanoparticle; transdermal patch
Mesh:
Substances:
Year: 2021 PMID: 34398404 DOI: 10.1007/s11095-021-03081-1
Source DB: PubMed Journal: Pharm Res ISSN: 0724-8741 Impact factor: 4.200